Clinicopathological factor | Relapse after steroid treatment | p Value | |
---|---|---|---|
With (n = 24, 58.5%) | Without (n = 17, 41.5%) | ||
Age of disease onset (years) | 54.7 ± 8.5 | 48.8 ± 16.3 | 0.135 |
Sex (male, %) | 50.0 | 47.1 | 0.853 |
Bilaterality (%) | 62.5 | 47.1 | 0.326 |
Lacrimal gland involvement (%) | 79.2 | 76.5 | 0.837 |
ln (serum IgG4 level) | 6.4 ± 0.99 | 5.0 ± 1.26 | 0.002* |
GC (LPF) | 7.2 ± 2.7 | 4.0 ± 2.4 | <â0.001* |
Pathological IgG4+ plasmacyte (HPF) | 155.7 ± 51.2 | 94.6 ± 49.0 | <â0.001* |
Pathological IgG+ plasmacyte (HPF) | 199.42 ± 58.5 | 167.0 ± 74.4 | 0.127 |
Pathological IgG4+/IgG+ ratio (%) | 80.4 ± 16.2 | 59.9 ± 21.8 | 0.001* |
Systemic involvement (head and neck, %) | 45.8 | 23.5 | 0.144 |